These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 16859607

  • 1. Sustained 3-year remission after rituximab treatment in a patient with refractory Wegener's granulomatosis.
    Tektonidou MG, Skopouli FN.
    Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S103. PubMed ID: 16859607
    [No Abstract] [Full Text] [Related]

  • 2. Refractory Wegener's granulomatosis: effect of rituximab on granulomatous bilateral orbital involvement.
    Avshovich N, Boulman N, Slobodin G, Zeina AR, Rosner I, Rozenbaum M.
    Isr Med Assoc J; 2009 Sep; 11(9):566-8. PubMed ID: 19960854
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener's granulomatosis: a case report.
    Ooka S, Maeda A, Ito H, Omata M, Yamada H, Ozaki S.
    Mod Rheumatol; 2009 Sep; 19(1):80-3. PubMed ID: 18806927
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Rituximab in refractory Wegener's granulomatosis: Favorable or not?
    Aries PM, Lamprecht P, Gross WL.
    Am J Respir Crit Care Med; 2006 Apr 01; 173(7):815-6; author reply 816. PubMed ID: 16556703
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of ANCA-associated vascularitides].
    Guillevin L, Pagnoux C.
    Presse Med; 2007 May 01; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Rituximab in refractory ophthalmic Wegener's granulomatosis: PR3 titers may predict relapse, but repeat treatment can be effective.
    Joshi L, Lightman SL, Salama AD, Shirodkar AL, Pusey CD, Taylor SR.
    Ophthalmology; 2011 Dec 01; 118(12):2498-503. PubMed ID: 21907416
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.
    Calich AL, Puéchal X, Pugnet G, London J, Terrier B, Charles P, Mouthon L, Guillevin L, French Vasculitis Study Group.
    J Autoimmun; 2014 May 01; 50():135-41. PubMed ID: 24703438
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Rituximab reversed cardiac involvement of Wegener's granulomatosis: magnetic resonance imaging assessment.
    Brihaye B, Aouba A, Pagnoux C, Vignaux O, Le Hello C, Guillevin L.
    Presse Med; 2008 Mar 01; 37(3 Pt 1):412-5. PubMed ID: 18276102
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Two cases of refractory Wegener's granulomatosis successfully treated with rituximab.
    Tamura N, Matsudaira R, Hirashima M, Ikeda M, Tajima M, Nawata M, Morimoto S, Kaneda K, Kobayashi S, Hashimoto H, Takasaki Y.
    Intern Med; 2007 Mar 01; 46(7):409-14. PubMed ID: 17409608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.